Radiological changes after stereotactic radiotherapy for stage I lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 7, 2011, Pages 1221-1228

  Dahele, Max ^a   Palma, David ^a   Lagerwaard, Frank ^a   Slotman, Ben ^a   Senan, Suresh ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Lung cancer; Radiation fibrosis; Radiation pneumonitis; Radiation therapy; Stereotactic

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FIBROSIS; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INCIDENCE; INJURY SEVERITY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RADIATION PNEUMONIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY;

EID: 79959917830     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318219aac5     Document Type: Article

References (31)

1. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27:3290-3296.
2. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-1076.
3. Grutters JP, Kessels AG, Pijls-Johannesma M, et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis. Radiother Oncol 2010;95: 32-40.
4. Palma D, Visser O, Lagerwaard FJ, et al. The impact of introducing stereotactic lung radiotherapy for elderly patients with stage I NSCLC: A population-based time-trend analysis. J Clin Oncol 2010;28:5153-5159.
5. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys In press.
6. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009;4:1.
7. Takeda A, Ohashi T, Kunieda E, et al. Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors. Int J Radiat Oncol Biol Phys 2010;77:685-690.
8. Palma DA, Senan S, Haasbeek CJ, et al. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: A matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys In press.
9. Guckenberger M, Heilman K, Wulf J, et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 2007;85:435- 442. Erratum in: Radiother Oncol 2008;86:293. (Pubitemid 350213147)
10. Trovo M, Linda A, El Naqa I, et al. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 2010;69:77-85.
11. Kyas I, Hof H, Debus J, et al. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007;67:768-774. (Pubitemid 46215862)
12. Baumann P, Nyman J, Hoyer M, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer-a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 2008;88:359-367.
13. Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483-489.
14. Mirri MA, Arcangeli G, Benassi M, et al. Hypofractionated conformal radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension: Efficacy and toxicity. Strahlenther Onkol 2009;185:27-33.
15. Matsuo Y, Nagata Y, Mizowaki T, et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007;12:356-362. (Pubitemid 47573413)
16. Aoki T, Nagata Y, Negoro Y, et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 2004;230:101-108. (Pubitemid 37549789)
17. Takeda T, Takeda A, Kunieda E, et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: Serial changes on CT. AJR Am J Roentgenol 2004;182:1123-1128. (Pubitemid 38525501)
18. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70:1057-1065. (Pubitemid 351296119)
19. Chi A, Liao Z, Nguyen NP, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiother Oncol 2010;94:1-11.
20. Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I non small cell lung cancer. Ann Thorac Surg 2003;76:1001-1007.
21. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-692.
22. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, et al. Stage I non small cell lung cancer in patients aged > or=75 years: Outcomes after stereotactic radiotherapy. Cancer 2010;116:406-414.
23. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2009. Available at: Http://www.goldcopd.org. Accessed December 2, 2010.
24. Faria SL, Aslani M, Tafazoli FS, et al. The challenge of scoring radiation-induced lung toxicity. Clin Oncol (R Coll Radiol) 2009;21: 371-375.
25. Linda A, Trovo M, Bradley JD. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: A timeline and pattern of CT changes. Eur J Radiol In press.
26. Palma DA, van Sörnsen de Koste JR, Verbakel WF, et al. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol In press.
27. Palma DA, van Sörnsen de Koste J, Verbakel WF, et al. Lung density changes after stereotactic radiotherapy: A quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys In press.
28. Stephans KL, Djemil T, Reddy CA, et al. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 2009;4:838-844.
29. Verbakel WF, Senan S, Cuijpers JP, et al. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensitymodulated arcs. Radiother Oncol 2009;93:122-124.
30. Neri S, Takahashi Y, Terashi T, et al. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J Thorac Oncol 2010;5:2003-2007.
31. Chen F, Matsuo Y, Yoshizawa A, et al. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. J Thorac Oncol 2010;5:1999 -2002.